Lars R. Perk

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine

Maria J.W.D. Vosjan, Lars R. Perk, Gerard W.M. Visser et al. · Nature Protocols · 2010 · 428 citations

Positron Emission Tomography, Engineering, Medical Imaging +10

Development and Characterization of Clinical-Grade ⁸⁹Zr-Trastuzumab for HER2/<i>neu</i> ImmunoPET Imaging

Eli Dijkers, Jos G. W. Kosterink, Anna P. Rademaker et al. · Journal of Nuclear Medicine · 2009 · 334 citations · Full text

In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft

Wouter B. Nagengast, Elisabeth G.E. de Vries, Geke A.P. Hospers et al. · Journal of Nuclear Medicine · 2007 · 313 citations · Full text

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

Lars R. Perk, Maria J.W.D. Vosjan, Gerard W.M. Visser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 213 citations · Full text

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

Lars R. Perk, Gerard W.M. Visser, Maria J.W.D. Vosjan et al. · PubMed · 2005 · 205 citations